Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 9Allegra
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2019 Revenue in Millions : 140
2018 Revenue in Millions : 135
Growth (%) : 3
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2019 Revenue in Millions : 475
2018 Revenue in Millions : 432
Growth (%) : 10
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2020 Revenue in Millions : 500
2019 Revenue in Millions : 527
Growth (%) : -5
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2014 Revenue in Millions : -52.70%
2013 Revenue in Millions :
Growth (%) :
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2015 Revenue in Millions : 211
2014 Revenue in Millions : 213
Growth (%) : 1%
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2016 Revenue in Millions : 197
2015 Revenue in Millions : 206
Growth (%) : -4
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2017 Revenue in Millions : 196
2016 Revenue in Millions : 231
Growth (%) : -15
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2018 Revenue in Millions : 140
2017 Revenue in Millions : 179
Growth (%) : -22%
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2018 Revenue in Millions : 447
2017 Revenue in Millions : 478
Growth (%) : -6%
LOOKING FOR A SUPPLIER?